MedPath
TGA Approval

NAD+ AAA (495386)

495386

NAD+ AAA

Renhe Biotech (Australia) Pty Ltd

June 30, 2025

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

methylselenocysteine

nadide

nicotinamide

nicotinic acid

Reynoutria japonica

Rhodiola rosea

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NAD+ AAA (495386) - TGA 批准文号 | MedPath